FR2157865B1 - - Google Patents

Info

Publication number
FR2157865B1
FR2157865B1 FR7236560A FR7236560A FR2157865B1 FR 2157865 B1 FR2157865 B1 FR 2157865B1 FR 7236560 A FR7236560 A FR 7236560A FR 7236560 A FR7236560 A FR 7236560A FR 2157865 B1 FR2157865 B1 FR 2157865B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7236560A
Other languages
French (fr)
Other versions
FR2157865A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2157865A1 publication Critical patent/FR2157865A1/fr
Application granted granted Critical
Publication of FR2157865B1 publication Critical patent/FR2157865B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7236560A 1971-10-29 1972-10-16 Expired FR2157865B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19400671A 1971-10-29 1971-10-29

Publications (2)

Publication Number Publication Date
FR2157865A1 FR2157865A1 (en) 1973-06-08
FR2157865B1 true FR2157865B1 (en) 1975-10-31

Family

ID=22715935

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7236560A Expired FR2157865B1 (en) 1971-10-29 1972-10-16

Country Status (25)

Country Link
JP (2) JPS5337870B2 (en)
AR (2) AR198798A1 (en)
AT (2) AT321308B (en)
AU (1) AU467600B2 (en)
BE (1) BE790125A (en)
CA (1) CA980778A (en)
CH (2) CH555832A (en)
DE (3) DE2248741C3 (en)
DK (1) DK131465B (en)
EG (1) EG11013A (en)
ES (2) ES407730A1 (en)
FI (1) FI55503C (en)
FR (1) FR2157865B1 (en)
GB (2) GB1377720A (en)
IE (1) IE37043B1 (en)
IL (2) IL40458A (en)
LU (1) LU66304A1 (en)
NL (1) NL166470C (en)
NO (1) NO136574C (en)
PH (2) PH10129A (en)
PL (2) PL84634B1 (en)
SE (2) SE393376B (en)
SU (2) SU498908A3 (en)
YU (2) YU35125B (en)
ZA (1) ZA727362B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55151912U (en) * 1979-04-17 1980-11-01
JPS5752409Y2 (en) * 1979-11-05 1982-11-15
DE3222914A1 (en) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg SUBSTITUTED 5-PHENYLTHIO-6-AMINO-PYRIMIDINONE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS
JPH0655686B2 (en) * 1988-08-30 1994-07-27 宇部興産株式会社 Process for producing p-bromophenoxyacetaldehyde dialkyl acetals
NZ565955A (en) 2005-08-22 2011-08-26 Melior Pharmaceuticals I Inc Methods and formulations for modulating lyn kinase activity and treating related disorders
US8552184B2 (en) 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
NZ758966A (en) 2017-04-10 2024-08-30 Board Of Supervisors Of Louisiana State Univ And Agricultural And Mechanical College Treatment of adipocytes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2913462A (en) * 1959-11-17 Eahl h
GB951432A (en) * 1959-03-17 1964-03-04 Wellcome Found Pyrimidine derivatives and the manufacture thereof

Also Published As

Publication number Publication date
FI55503C (en) 1979-08-10
NO136574C (en) 1977-09-28
JPS5422995B2 (en) 1979-08-10
NL166470B (en) 1981-03-16
DE2248741C3 (en) 1975-06-26
DE2264374A1 (en) 1973-05-24
LU66304A1 (en) 1973-05-03
AU467600B2 (en) 1975-12-04
GB1377720A (en) 1974-12-18
SE397090B (en) 1977-10-17
AR198798A1 (en) 1974-07-24
JPS4852780A (en) 1973-07-24
AT321308B (en) 1975-03-25
GB1377308A (en) 1974-12-11
DE2248741A1 (en) 1973-05-03
PL89852B1 (en) 1976-12-31
IL40458A (en) 1976-05-31
ES407730A1 (en) 1976-01-16
IL48790A (en) 1976-05-31
DK131465C (en) 1975-12-08
FR2157865A1 (en) 1973-06-08
PH11594A (en) 1978-03-31
IE37043B1 (en) 1977-04-27
BE790125A (en) 1973-04-16
AT320656B (en) 1975-02-25
NL166470C (en) 1981-08-17
SE7505279L (en) 1975-05-06
JPS5337870B2 (en) 1978-10-12
NO136574B (en) 1977-06-20
PL84634B1 (en) 1976-04-30
DK131465B (en) 1975-07-21
YU255172A (en) 1980-03-15
PH10129A (en) 1976-09-02
DE2264374C3 (en) 1981-07-23
SU498908A3 (en) 1976-01-05
YU35125B (en) 1980-09-25
IL40458A0 (en) 1972-11-28
EG11013A (en) 1976-11-30
IL48790A0 (en) 1976-03-31
DE2264657A1 (en) 1974-06-20
SE393376B (en) 1977-05-09
ES436624A1 (en) 1977-02-01
CA980778A (en) 1975-12-30
YU99179A (en) 1981-08-31
ZA727362B (en) 1973-11-28
DE2264374B2 (en) 1980-08-07
DE2248741B2 (en) 1974-11-14
AU4722872A (en) 1974-04-04
CH549579A (en) 1974-05-31
IE37043L (en) 1973-04-29
JPS53116386A (en) 1978-10-11
NL7213959A (en) 1973-05-02
AR196263A1 (en) 1973-12-10
CH555832A (en) 1974-11-15
YU36295B (en) 1982-06-18
FI55503B (en) 1979-04-30
DE2264657C2 (en) 1982-09-16
SU505362A3 (en) 1976-02-28

Similar Documents

Publication Publication Date Title
DK131465C (en)
AU2691671A (en)
AU2742671A (en)
AU2894671A (en)
AU3005371A (en)
AU2941471A (en)
AU2952271A (en)
AU2684071A (en)
AU2940971A (en)
AU2880771A (en)
AU2669471A (en)
AU3038671A (en)
AU3025871A (en)
AU2836771A (en)
AU2684171A (en)
AU2963771A (en)
AR202997Q (en)
AU2706571A (en)
AU2854371A (en)
AU2938071A (en)
AU2724971A (en)
AU1109576A (en)
AU2930871A (en)
AU2927871A (en)
AU2907471A (en)

Legal Events

Date Code Title Description
ST Notification of lapse